Product NDC: | 0406-8315 |
Proprietary Name: | MORPHINE SULFATE |
Non Proprietary Name: | MORPHINE SULFATE |
Active Ingredient(s): | 15 mg/1 & nbsp; MORPHINE SULFATE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0406-8315 |
Labeler Name: | Mallinckrodt, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076412 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101021 |
Package NDC: | 0406-8315-23 |
Package Description: | 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8315-23) |
NDC Code | 0406-8315-23 |
Proprietary Name | MORPHINE SULFATE |
Package Description | 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8315-23) |
Product NDC | 0406-8315 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | MORPHINE SULFATE |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20101021 |
Marketing Category Name | ANDA |
Labeler Name | Mallinckrodt, Inc. |
Substance Name | MORPHINE SULFATE |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |